INTRODUCTION
. 25-OH-D 3 is mainly derived from vitamin D 3 produced by sunlight in the skin, while 25-OH-D 2 is derived from plants in the diet. [1] [2] [3] [4] There are currently two main types of methods used routinely for measuring 25-OH-D: methods based on chromatographic separation followed by non-immunological direct detection and competitive immunoassays. Most immunoassays depend on an antibody that can detect both 25-OH-D 2 and 25-OH-D 3 , but the proportion of 25-OH-D 2 detection is variable [1] [2] [3] [4] [5] . Two non-immunological methods for direct detection are currently available: high pressure liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/ MS) [1] . The HPLC is usually connected to an ultraviolet detector (HPLC-UV) or an electrochemical detector [2] . If HPLC is attached to mass detectors, the procedure is commonly termed LC-MS/MS or tandem mass spectrometry. Initial purification is required prior to chromatographic separation [1, 3] . LC-MS/MS is considered a reference method [4, 6] although for LC-MS/ MS there is lack of consistency in the way these procedures are standardized [2, 7] . The advantages of LC-MS/ MS are the reliability, low batch-to-batch variation and low limit of detection (2.5 nmol/L) [3] . Additionally, LC-MS/MS methods are able to measure 25-OH-D 2 and 25-OH-D 3 independently with good recoveries [1] [2] [3] [4] . The major disadvantage is the time-consuming and laborious extraction procedure that limits the number of samples that can be processed per day. However, several laboratories have now automated the sample pretreatment process, so the low throughput will not be a problem in the future [4] . Currently, LC-MS/MS methods are usually in-house assays. Recently 
MATERIALS AND METHODS

Serum samples
The leftover de-identified serum samples (n = 400, 263 females and 137 males) were randomly chosen from routine samples analyzed in the laboratory of Oulu University Hospital. The mean age of patients was 54.1 years (interval 0.8 -100.8 years); that of females was 56.5 years (interval 0.8 -100.8 years) and of males 49.4 years (interval 1.0 -89.3 years). The number of samples from children (age < 16 years) was 21 : 14 girls (interval 0.8 -15.9 years) and 7 boys (interval 1.0 -15.7). All measurements were performed by single assays. Samples were separated within two hours after collection and analyzed first by Liaison ® 25 OH Vitamin D TOTAL assay. After the analysis, the samples were divided into four aliquots and frozen (at -20°C) for further analysis because the analyzers used in this study were located in different hospitals. Before analysis by the ADVIA Centaur ® , the samples were stored again at -20°C before re-analysis.
Liaison
® 25OH Vitamin D TOTAL The Liaison ® 25OH Vitamin D TOTAL (DiaSorin, Stillwater, MN, USA) antibody-based 25-OH-vitamin D assay is a fully automated, random-access direct competitive two-step chemiluminescent system. During the first incubation, 25-OH-D is dissociated from its binding protein and binds to the specific antibody on the solid phase. After 10 minutes, the tracer (25-OH-vitamin D linked to an isoluminol derivate) is added. After a sec-ond 10-minute incubation, the unbound material is removed with a wash cycle. Subsequently, the starter reagents are added to initiate a chemiluminescent reaction.
IDS-iSYS 25-Hydroxy Vitamin D
The fully automated IDS-iSYS (IDS plc, Boldon, UK) 25-Hydroxy Vitamin D assay is intended for the quantitative determination of 25-OH-D and other hydroxyllated metabolites. The assay is based on chemiluminescence technology. Samples are subjected to a pretreatment step to denature the 25-OH-vitamin D binding protein (VDBP). The treated samples are then neutralized in an assay buffer and a specific anti-25-OH-D antibody labeled with acridinium ester is injected. Following an incubation step, paramagnetic particles linked to 25-OH-D are added. After a washing step and addition of trigger reagents, the light emitted by the acridinium label is inversely proportional to the concentration of 25-OH-D in the original sample. Table 1 . H 6 -25-OH-D 3 in charcoal stripped human serum. The derivatization reagent used is PTAD (4-Phenyl-1,2,4-triazoline-3,5-dione). The samples were prepared using a protein precipitation protocol. 100 µL of sample (serum, plasma, calibrator or control) was transferred into a 96-well plate (500 µL NUNC plate included in the kit) before the addition of 200 µL of a solution (acetonitrile with 0.1% formic acid) containing deuterium-labeled IS. The plate was covered and shaken at 750 rpm at room temperature (RT) for 10 minutes and the samples were centrifuged at 4210 RCF, at +4 to +30°C for 30 minutes. 150 µL of the supernatant obtained was transferred into another plate and dried under a gentle flow of nitrogen gas. 50 µL of PTAD reagent was added to the residue contained in each well, after which the plate was shaken at 750 rpm at RT for 10 minutes. Finally, 50 µL of quench solution was added to the plate, shaken again (at 750 rpm at RT for 10 minutes) and then loaded onto the auto-sampler (at +4 to 25°C) for the LC-MS/MS analysis. The HPLC-MS/MS system consisted of a Waters 1525u binary HPLC system coupled to a Waters TQD triple quadrupole mass spectrometry (Waters Corp., Manchester, UK). The instrument was operated in a positive electrospray ionization mode. For HPLC analysis the Waters XBridge C8 3.5 µm 2.1 x 100 mm column was used. The mobile phase solvents were Mobile Phase A: 50% (v/v) solution of methanol in water containing 0.025% (v/v) of HPLC solvent additive and Mobile Phase B: methanol containing 0.025% (v/v) of HPLC solvent additive. Gradient composition started from 50% B and it was maintained for 1.0 minute. The mobile phase gradient profile involved two steps: increasing from initial conditions to 75% B within 5 minutes and then to 100% B within 0.1 minute holding for 2 minutes before returning to the initial state at 8.1 minutes, allowing 1 minute for column re-equilibration. The run time was 9 minutes. Flow rate was 300 µL/minute and 50 µL of sample was injected. The column temperature was set at 40°C. The MS-MS analysis was done in multiple reaction monitoring (MRM) mode following the ion transitions with appropriate instrumental parameters as described in table 2. The capillary voltage was 3.5 KV, source temperature was 100°C, desolvation gas flow 100 L/h at 450°C and collision gas argon kept at a pressure of 1.97 x 10 -3 . Data were acquired with Mass Lynx 4.1 Software (Waters) and processed for calibra- 
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 25-OH D
Statistical analysis
Results of the assay methods were first presented by box plot (reported as mean 95% confidence interval (CI) and standard deviation (SD)) and compared by Pearson correlation coefficient (r). However, in the case of method-to-method comparison, unbiased PassingBablok regressions are suitable. Therefore Passing-Bablok fits were used to calculate slopes and intercepts between the analysis methods. If two methods are compared by Passing-Bablok fit and they give similar results, the 95% CI of slope should include value 1 and the 95% CI of intercept value 0 [9] . 
RESULTS
The mean and 95% CI intervals of the assays compared in this study are presented in Figure 1 and in Table 3A . Furthermore, the LC-MS/MS mean of 25-OH-D 3 was 79.3 (75.9 to 82.7) nmol/L while the mean of LC-MS/MS 25-OH-D 2 was 3.5 (3.0 to 4.0) nmol/L.
Comparisons of four immunoassays to LC-MS/MS
Pearson's linear r between immunoassays and LC-MS/ MS-total-D are presented in Table 3B . The low levels of 25-OH-D 2 in the samples could not contribute to the differences between the immunoassays and the LC-MS/MS method since Pearson's linear r values between the immunoassays and LC-MS/MS 25-OH-D 3 were similar (data not shown) as presented in Table 3B . All linear correlations were significant at the 0.0001 level but individual samples may have significant differences between the methods; linear correlation may thus not be the best statistical test. In this study, regarding Passing-Bablok regression fits, none of the immunoassays gave equivalent results to LC-MS/MS (Table 3B) Table 1 ). On the other hand, their major weakness is the inability to quantitate 25-OH-D 2 and 25-OH-D 3 separately when these commercial immunoassays measure total 25-OHvitamin D concentrations. It is shown here once again that 25-OH-D is a difficult analyte [13, 14] . There are two main reasons for this. There are several different molecular forms of 25-OHvitamin D in the serum [1] . These have a hydrophobic nature and will bind tightly to VDBP. Before analyzing 25-OH-vitamin D with any method, pretreatment of the sample is necessary. Pretreatment can include deproteinization or extraction, purification and finally quantification [1] . However, the details of the denaturing agents used in the immunoassays are not available, because they are regarded as commercial secrets. These matrix effects can lead to modest inter-laboratory variability in immunoassays [5] . However, the earlier 25-OH-vitamin D assays based on binding proteins were more susceptible to matrix effect than immunoassays that use antibodies for a sandwich assay [13] . In some individual patient sera, matrix effects distorting the displacement of 25-OH-D from its binding protein may cause great inter-method variability [15] . A second reason introducing variability is the standardization of the assay. Indeed, there is a need for a common international standard for the calibration of 25-OH-D assays. The National Institute of Standard and Technology (NIST) has developed standard reference material (SRM) for 25-OH-vitamin D analysis [1, 2, 4] . Some companies report using this SRM in the calibration of their assays. Regardless of the SRM calibration of the assays there is still discrepancy between the methods. When analyzing the samples in this study harmonization of the immunoassays had already been performed as suggested [16] . Recently, Holmes et al. [17] reported non-linear analytical recovery in the Liaison 25-OH-D immunoassay. The calibration of ADVIA Centaur ® Vitamin D Total was also adjusted in low concentration (50 nmol/L) [18] . Abbott restandardized the calibrators and controls of the ARCHITECT 25-OH Vitamin D following our study [19] . LC-MS/MS is proposed as the reference method for 25-OH-vitamin D measurement. In this study, regarding Passing-Bablok regression fits, none of the immunoassays gave equivalent results to LC-MS/MS. Potential explanations may be sample treatment or a technical aspect of chromatography or mass spectrometry. We found that there were some problems with this commercial LC-MS/MS method (Figure 2 ). LC-MS/MS and HPLC release the 25-OH-D from its binding protein followed by protein precipitation before chromatography and final quantification [12] . Chromatographic methods are less susceptible to sample matrix effects than immunoassays [7] . Chromatography has two areas of concern where analytical errors can occur. Firstly, the presence of interfering compounds is problematic when they elute at the same time as the analyte being measured. Secondly, the calibration issue noted above; the recent availability of NIST ethanol-based standards should resolve calibration problems and allow laboratories to trace their calibrators to the NIST material [5] . The measurement of 25-OH-D is technically demanding due to its strong binding to protein [15] . However, in LC-MS/MS ion suppression can reduce the performance of the mass detector. Ion suppression can be caused by non-volatile compounds [1, 3] . In Finland, vitamin D deficiency is defined as a serum 25-OH-D level lower than the reference range (40 nmol/L). In this study, we found patients who had a clinically negative result measured by the LC-MS/MS method manufactured by PerkinElmer but positive results by all immunoassays. Three of these samples were reanalyzed using another LC-MS/MS method, and we found that the commercially available LC-MS/MS method gave too low concentrations at least in these three samples. Since this method was correctly standardized the problem should be the pretreatment of the samples before analysis. Additionally, in this study some patients had a clinically positive result measured by the reference method (LC/MS-MS) but negative results by all immunoassays. There is continuous debate as to which is the best method of 25-OH-D measurement for routine clinical laboratory and research use. It is clear that both immunoassays and LC-MS/MS methods have advantages and limitations. The strengths of the measurement of 25-OH-D by immunoassays are convenience, speed, turnaround, and cost [12, 20] . On the other hand, LC-MS/MS is a rapid, accurate, sensitive, and cost-effective alternative to other methods, its real advantage being the ability to report both 25-OH-D 3 and 25-OH-D 2 but reporting 25-OH-D 3 and 25-OH-D 2 separately may cause confusion among clinicians [4, 15, 21] . Two (the IDS-iSYS, the ADVIA Centaur ® ) out of four automated 25-OH-D assays were better than the others when compared with the commercial LC-MS/MS. In conclusion, in routine clinical laboratory analyses both immunoassays and LC-MS/MS are useful for measuring 25-OH-vitamin D, provided that these methods are correctly standardized and especially sample pretreatment is carefully done.
DISCUSSION
